Hepa vaccine adult im
Products billed under this code include Havrix, Vaqta.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Havrix, Vaqta.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Havrix | A-S Medication Solutions | 50090-1502-00 | 10 | $749.24 |
| Havrix | GlaxoSmithKline LLC | 58160-0826-52 | 10 | $749.24 |
| Vaqta | Merck Sharp & Dohme LLC | 00006-4096-02 | 10 | $749.24 |
| Vaqta | Merck Sharp & Dohme LLC | 00006-4841-41 | 10 | $749.24 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $74.924 | −$0.811 | 1 ML | Hepa vaccine adult im | v1, posted September 17, 2026 |
| 3Q26 | $75.735 | +$2.007 | 1 ML | Hepa vaccine adult im | v1, posted September 15, 2026 |
| 2Q26 | $73.728 | +$0.186 | 1 ML | Hepa vaccine adult im | v1, posted September 15, 2026 |
| 1Q26 | $73.542 | −$0.252 | 1 ML | Hepa vaccine adult im | v1, posted September 15, 2026 |
| 4Q25 | $73.794 | +$1.11 | 1 ML | Hepa vaccine adult im | v1, posted September 8, 2026 |
| 3Q25 | $72.684 | +$0.527 | 1 ML | Hepa vaccine adult im | v1, posted March 10, 2026 |
| 2Q25 | $72.157 | +$0.549 | 1 ML | Hepa vaccine adult im | v1, posted March 10, 2026 |
| 1Q25 | $71.608 | +$1.132 | 1 ML | Hepa vaccine adult im | v1, posted December 19, 2025 |
| 4Q24 | $70.476 | −$0.095 | 1 ML | Hepa vaccine adult im | v1, posted June 11, 2025 |
| 3Q24 | $70.571 | +$0.03 | 1 ML | Hepa vaccine adult im | v1, posted June 11, 2025 |
| 2Q24 | $70.541 | +$0.28 | 1 ML | Hepa vaccine adult im | v1, posted March 11, 2025 |
| 1Q24 | $70.261 | +$0.183 | 1 ML | Hepa vaccine adult im | v1, posted December 19, 2024 |
| 4Q23 | $70.078 | −$1.775 | 1 ML | Hepa vaccine adult im | v1, posted October 10, 2024 |
| 3Q23 | $71.853 | +$1.75 | 1 ML | Hepa vaccine adult im | v1, posted June 5, 2024 |
| 2Q23 | $70.103 | −$0.066 | 1 ML | Hepa vaccine adult im | v1, posted February 23, 2024 |
| 1Q23 | $70.169 | −$0.813 | 1 ML | Hepa vaccine adult im | v1, posted December 6, 2023 |
| 4Q22 | $70.982 | +$2.237 | 1 ML | Hepa vaccine adult im | v1, posted June 22, 2023 |
| 3Q22 | $68.745 | +$3.05 | 1 ML | Hepa vaccine adult im | v1, posted June 9, 2023 |
| 2Q22 | $65.695 | +$0.958 | 1 ML | Hepa vaccine adult im | v1, posted December 14, 2022 |
| 1Q22 | $64.737 | +$0.66 | 1 ML | Hepa vaccine adult im | v1, posted June 8, 2022 |
| 4Q21 | $64.077 | +$1.164 | 1 ML | Hepa vaccine adult im | v1, posted June 2, 2022 |
| 3Q21 | $62.913 | +$4.151 | 1 ML | Hepa vaccine adult im | v1, posted June 2, 2022 |
| 2Q21 | $58.762 | −$1.934 | 1 ML | Hepa vaccine adult im | v1, posted March 1, 2022 |
| 1Q21 | $60.696 | – | 1 ML | Hepa vaccine adult im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.